ThinkingAcross the Spectrum of Policy, Practice, Research & Reality

A blog about anything related to addiction, treatment, or recovery, all the way from prevention to building recovery-friendly communities. We also welcome guest bloggers here!

space

Pain: Sensation or Emotion?

March 28, 2019 by C. Scott McMillin

…optimally, the goal isn’t just to get different specialists to work together, it’s to educate all practitioners to address the patient with awareness of both perspectives.

Topics: , ,


Opioids in Cars

March 25, 2019 by C. Scott McMillin

The research team examined 24 years of cases and concluded the impairment was attributable to opioids.

Topics: ,


The Pot Wars Continue

March 11, 2019 by C. Scott McMillin

I think the problem is I have read the research, and it didn’t confirm the claims made on its behalf.

Topics: ,


Ketamine Comeback

March 7, 2019 by C. Scott McMillin

…for a casual reader, anecdotes such as hers are like commercials for drug use.

Topics: ,


LSD in the UK

March 4, 2019 by C. Scott McMillin

I recall several cases admitted to the inpatient psych ward at one hospital where I worked in Boston, usually with severe psychotic symptoms.

Topics:


Chrontact Has Been Made…

February 28, 2019 by C. Scott McMillin

Now, with legalization, “cannabusiness” is being commercialized along the lines of alcohol and tobacco.

Topics:


A Price We Can Afford

February 25, 2019 by C. Scott McMillin

Investors naturally seek to increase the value of their investment, while patients seek access to medication they need at a price they can afford.

Topics: ,


Does Vaping Help Smokers Quit?

February 21, 2019 by C. Scott McMillin

Though recent headlines insist that vaping is almost twice as effective than alternatives, that doesn’t mean it’s especially effective.

Topics:


Debate About New Painkillers

February 18, 2019 by C. Scott McMillin

I can imagine a hundred scenarios in which Dsuvia somehow leaves the battlefield and finds it way into the world of drug abuse.

Topics: , ,


Opioid Disorders and Depression

February 11, 2019 by C. Scott McMillin

The increased incidence of depression, anxiety, and other psychiatric symptoms linked to OUD may also help to account for high rates of relapse among patients, post-treatment, versus other substance disorders.

Topics: ,


Subscribe to RecoverySI via Email

Join 3,486 other subscribers


New Content


 


Top Commenters

24 comments
Joyce Goodale
12 comments
9 comments
8 comments

Most Viewed



RecoverySI on Twitter